Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hanmi Pharmaceutical
Biotech
Aptose exits cancer pact after Hanmi buyout blocks development
Aptose Biosciences has scrapped a deal for a blood cancer drug candidate as part of its pending takeover by Hanmi Pharmaceutical.
Nick Paul Taylor
May 14, 2026 6:35am
Gilead pumps up virology pipeline with drug transporter deal
Sep 29, 2025 10:35am
Aptose to pay Hanmi up to $420M for myeloid inhibitor
Nov 4, 2021 10:37am
Hanmi's Type 2 diabetes drug curbs cardiovascular, kidney issues
Jun 28, 2021 5:19pm
Merck bags J&J castoff from Hanmi to expand NASH pipeline
Aug 4, 2020 6:51am
Sanofi culls pipeline dud, still looking to out-license meds
Apr 24, 2020 8:10am
